Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
Ранг среди акций #28059
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Цена акции
$1.51
Последняя синхронизация: 2026-07-31
Рыночная капитализация
$28.82M
Изменение (1 день)
-0.33%
Изменение (1 год)
-57.49%
Страна
IT
Торговля Genenta Science S.p.A. (GNTA)

Категория

История цены акций Genenta Science S.p.A. (GNTA)
Наивысшая цена закрытия: $1.55 2026-07-01

Наименьшая цена закрытия: $11.33 2021-12-01
История цены акций Genenta Science S.p.A. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 7.52%
2025 -68.48%
2024 -0.35%
2023 -6.83%
2022 -51.72%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$122.11 -14.02%
AU
$753.28 5.84%
CH